US OptionsDetailed Quotes
BLND240719P3000
- 0.10
- 0.000.00%
15min DelayClose Jul 19 15:55 ET
0.10High0.10Low
0.10Open0.10Pre Close25 Volume0 Open Interest3.00Strike Price250.00Turnover1267.56%IV7.05%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.3534Delta0.9525Gamma31.20Leverage Ratio-2.0891Theta0.0000Rho-11.03Eff Leverage0.0001Vega
Blend Labs Stock Discussion
Sign in to post a comment
Bold Moves in Fintech: Blend Labs Secures $150 Million from Haveli Investments.
Blend Labs has announced a strategic partnership with Haveli Investments, marked by a substantial $150 million investment. This collaboration signals a robust vote of confidence in Blend's innovative approach to transforming financial services. Blend Labs, co-founded by visionary Nima Ghamsari, has been at the forefront of revolutionizing mort...
Blend Labs has announced a strategic partnership with Haveli Investments, marked by a substantial $150 million investment. This collaboration signals a robust vote of confidence in Blend's innovative approach to transforming financial services. Blend Labs, co-founded by visionary Nima Ghamsari, has been at the forefront of revolutionizing mort...
Sure, HFs actively trade around positions and what you see might not be completely relevant.
But it's a way to find interesting companies and ideas that you otherwise wouldn't have found.
A thread on this week's major HF 13-F filings ...![]()
1/ Pershing Square Capital
Bill Ackman wasn't fairly active this quarter.
His only move:
• Adding 16.70% to Howard Hughes $The Howard Hughes(HHC.US$
2/ Chuck Akre: Akre Capital Management
Akre's fund made a ton of moves this past quart...
But it's a way to find interesting companies and ideas that you otherwise wouldn't have found.
A thread on this week's major HF 13-F filings ...
1/ Pershing Square Capital
Bill Ackman wasn't fairly active this quarter.
His only move:
• Adding 16.70% to Howard Hughes $The Howard Hughes(HHC.US$
2/ Chuck Akre: Akre Capital Management
Akre's fund made a ton of moves this past quart...
+2
21
Upgrades
• $Air Products & Chemicals(APD.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $290 (from $288)
• $CME Group(CME.US$ : Oppenheimer Upgrades to Outperform from Perform - PT $223
• $Equitable(EQH.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $36
• $Diamondback Energy(FANG.US$ : Barclays Upgrades to Overweight from Equalweight - PT $160 (from $162)
• $Kilroy Realty Corp(KRC.US$ : Goldman Sachs Upgrades to Buy from Neu...
• $Air Products & Chemicals(APD.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $290 (from $288)
• $CME Group(CME.US$ : Oppenheimer Upgrades to Outperform from Perform - PT $223
• $Equitable(EQH.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $36
• $Diamondback Energy(FANG.US$ : Barclays Upgrades to Overweight from Equalweight - PT $160 (from $162)
• $Kilroy Realty Corp(KRC.US$ : Goldman Sachs Upgrades to Buy from Neu...
7
Upgrades
• $DCP Midstream(DCP.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's(LESL.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $Logitech International(LOGI.US$ : Goldman Sachs Upgrades to Buy from Neutral
• $NIO Inc(NIO.US$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet(OLLI.US$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals(ORIC.US$ : Citigro...
• $DCP Midstream(DCP.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's(LESL.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $Logitech International(LOGI.US$ : Goldman Sachs Upgrades to Buy from Neutral
• $NIO Inc(NIO.US$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet(OLLI.US$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals(ORIC.US$ : Citigro...
16
Gainers
• $GameStop(GME.US$ +14.16% (to seek approval for 3.33-for-l stock split)
• $Sage Therapeutics(SAGE.US$ +5.7% (announces presentation of promising results from the Phase 2 LUMINARY Study of SAGE-718 in patients with mild cognitive impairment and mild dementia due to Alzheimer's Disease)
• $Baozun(BZUN.US$ +6% (announces repurchase right notification for 1.625% Convertible Senior Notes due 2024)
• $XPeng(XPEV.US$ +8.9% (annou...
• $GameStop(GME.US$ +14.16% (to seek approval for 3.33-for-l stock split)
• $Sage Therapeutics(SAGE.US$ +5.7% (announces presentation of promising results from the Phase 2 LUMINARY Study of SAGE-718 in patients with mild cognitive impairment and mild dementia due to Alzheimer's Disease)
• $Baozun(BZUN.US$ +6% (announces repurchase right notification for 1.625% Convertible Senior Notes due 2024)
• $XPeng(XPEV.US$ +8.9% (annou...
28
2
Upgrades
• $Centennial Resource Development(CDEV.US$ : Stifel Upgrades to Buy from Hold - PT $11.20 (from $8.40)
• $Comerica(CMA.US$ : Goldman Sachs Upgrades to Buy from Sell - PT $112 (from $102)
• $Comerica(CMA.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $115 (from $108)
• $Five Below(FIVE.US$ : Citigroup Upgrades to Buy From Neutral
• $Tellurian(TELL.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $8 (from $5.50)
• $Vertiv Holdings(VRT.US$ : JP Morg...
• $Centennial Resource Development(CDEV.US$ : Stifel Upgrades to Buy from Hold - PT $11.20 (from $8.40)
• $Comerica(CMA.US$ : Goldman Sachs Upgrades to Buy from Sell - PT $112 (from $102)
• $Comerica(CMA.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $115 (from $108)
• $Five Below(FIVE.US$ : Citigroup Upgrades to Buy From Neutral
• $Tellurian(TELL.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $8 (from $5.50)
• $Vertiv Holdings(VRT.US$ : JP Morg...
28
3
Gainers
• $Anaplan(PLAN.US$ +28.2% (to be acquired by Thoma Bravo for $66.00 per share)
• $Guess(GES.US$ +5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
• $Membership Collective(MCG.US$ +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
• $Sorrento Therapeutics(SRNE.US$ +2.3% (reports promising results with a universal...
• $Anaplan(PLAN.US$ +28.2% (to be acquired by Thoma Bravo for $66.00 per share)
• $Guess(GES.US$ +5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
• $Membership Collective(MCG.US$ +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
• $Sorrento Therapeutics(SRNE.US$ +2.3% (reports promising results with a universal...
19
1
No comment yet
I Am 102927471 :